Advertisement

Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study

      Highlights

      • Our study validated the exploratory findings of Martinelli et al. on clustering EORTC QLQ-C30 scales.
      • Three main clusters were identified using data from 20,066 patients with cancer.
      • The three clusters included physical, psychological and gastro-intestinal related clusters.
      • Clusters were consistent across most socio-demographic and clinical characteristics.
      • The results may aid symptom burden management and inform clinical trial design.

      Abstract

      Introduction

      The European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) measures 15 health-related quality of life (HRQoL) scales relevant to the disease and treatment of patients with cancer. A study by Martinelli (2011) demonstrated that these scales could be grouped into three main clusters: physical, psychological and gastrointestinal. This study aims to validate Martinelli's findings in an independent dataset and evaluate whether these clusters are consistent across cancer types and patient characteristics.

      Methods

      Pre-defined criteria for successful validation were three main clusters should emerge with a minimum R-squared value of 0.51 using pooled baseline-data. A cluster analysis was performed on the 15 QLQ-C30 HRQoL-scales in the overall dataset, as well as by cancer type and selected patient characteristics to examine the robustness of the results.

      Results

      The dataset consisted of 20,066 patients pooled across 17 cancer types. Overall, three main clusters were identified (R2 = 0.61); physical-cluster included role-functioning, physical-functioning, social-functioning, fatigue, pain, and global-health status; psychological-cluster included emotional-functioning, cognitive-functioning, and insomnia; gastro-intestinal-cluster included nausea/vomiting and appetite loss. The results were consistent across different levels of disease severity, socio-demographic and clinical characteristics with minor variations by cancer type. Global-health status was found to be strongly linked to the scales included in the physical-functioning-related cluster.

      Conclusion

      This study successfully validated prior findings by Martinelli (2011): the QLQ-C30 scales are interrelated and can be grouped into three main clusters. Knowing how these multidimensional HRQoL scales are related to each other can help clinicians and patients with cancer in managing symptom burden, guide policymakers in defining social-support plans and inform selection of HRQoL scales in future clinical trials.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fan G.
        • Filipczak L.
        • Chow E.
        Symptom clusters in cancer patients: a review of the literature.
        Curr Oncol. 2007; 14: 173-179https://doi.org/10.3747/co.2007.145
        • Olschewski M.
        • Schumacher M.
        Statistical analysis of quality-of-life data in cancer clinical trials.
        Stat Med. 1990; 9: 749-763https://doi.org/10.1002/sim.4780090705
        • Fiteni F.
        • Westeel V.
        • Pivot X.
        • Borg C.
        • Vernerey D.
        • Bonnetain F.
        Endpoints in cancer clinical trials.
        J Visceral Surg. 2014; 151: 17-22https://doi.org/10.1016/j.jviscsurg.2013.10.001
        • Anota A.
        • Hamidou Z.
        • Paget-Bailly S.
        • et al.
        Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?.
        Qual Life Res. 2015; 24: 5-18https://doi.org/10.1007/s11136-013-0583-6
        • Bottomley A.
        • Pe M.
        • Sloan J.
        • et al.
        Analyzing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
        Lancet Oncol. 2016; 17: e510-e514https://doi.org/10.1016/S1470-2045(16)30510-1
        • Fayers P.M.
        • Hopwood P.
        • Harvey A.
        • Girling D.J.
        • Machin D.
        Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers.
        UK Med Res Counc Exp. 1997; 33: 20-28https://doi.org/10.1016/S0959-8049(96)00412-1
        • Calvert M.
        • Kyte D.
        • Mercieca-Bebber R.
        • et al.
        Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension.
        JAMA. 2018; 319: 483-494https://doi.org/10.1001/jama.2017.21903
        • Coens C.
        • Pe M.
        • Dueck A.C.
        • et al.
        International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomized controlled trials: recommendations of the SISAQOL Consortium.
        Lancet Oncol. 2020; 21: e83-e96https://doi.org/10.1016/s1470-2045(19)30790-9
        • Matzka M.
        • Köck-Hódi S.
        • Jahn P.
        • et al.
        Relationship among symptom clusters, quality of life, and treatment-specific optimism in patients with cancer.
        Support Care Cancer. 2018; 26: 2685-2693https://doi.org/10.1007/s00520-018-4102-8
        • Walsh D.
        • Rybicki L.
        Symptom clustering in advanced cancer.
        Support Care Cancer. 2006; 14: 831-836https://doi.org/10.1007/s00520-005-0899-z
        • Chow E.
        • Fan G.
        • Hadi S.
        • Wong J.
        • Kirou-Mauro A.
        • Filipczak L.
        Symptom clusters in cancer patients with brain metastases.
        Clin Oncol. 2008; 20: 76-82https://doi.org/10.1016/j.clon.2007.09.007
        • Fan G.
        • Filipczak L.
        • Chow E.
        Symptom clusters in cancer patients: a review of the literature.
        Curr Oncol. 2007; 14 (https://doi.org/10.3747/co.2007.145): 173-179https://doi.org/10.3747/co.2007.145
        • Ediebah D.E.
        • Coens C.
        • Zikos E.
        • et al.
        Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
        Br J Cancer. 2014 May 13; 110 (Epub 2014 Apr 17. PMID: 24743709; PMCID: PMC4021536): 2427-2433https://doi.org/10.1038/bjc.2014.208
        • Fiteni F.
        • Vernerey D.
        • Bonnetain F.
        • et al.
        Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
        Eur J Cancer. 2016 Jan; 52 (Epub 2015 Dec 10. PMID: 26682871): 120-128https://doi.org/10.1016/j.ejca.2015.10.004
        • Martinelli F.
        • Quinten C.
        • Maringwa J.T.
        • et al.
        Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
        Expert Rev Pharmacoecon Outcomes Res. 2011; 11: 587-599https://doi.org/10.1586/erp.11.51
      1. Project data Sphere. https://www.projectdatasphere.org/.

        • Aaronson N.K.
        • Ahmedzai S.
        • Bergman B.
        • et al.
        The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
        J Natl Cancer Inst. 1993; 85: 365e376https://doi.org/10.1093/jnci/85.5.365
        • Koller M.
        • Aaronson N.K.
        • Blazeby J.
        • et al.
        Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach.
        Eur J Cancer. 2007; 43: 1810-1820https://doi.org/10.1016/j.ejca.2007.05.029
        • Fayers P.M.
        • Aaronson N.K.
        • Bjordal K.
        • Groenvold M.
        • Curran D.
        • Bottomley A.
        • on behalf of the EORTC Quality of Life Group
        The EORTC QLQ-C30 scoring manual.
        3rd ed. European Organisation for Research and Treatment of Cancer, Brussels, Belgium2001 ([EORTC scoring manual])
        • James Gareth M.
        • Hastie Trevor
        • Witten Daniela
        • Tibshirani Robert
        An introduction to statistical learning: with applications in R. vol. 103. 978-1-4614-7137-0 Springer, 2013: 385-410
        • Yu C.H.
        An introduction to computing and interpreting Cronbach Coefficient Alpha in SAS.
        2001
        • Gundy C.M.
        • Fayers P.M.
        • Groenvold M.
        • et al.
        Comparing higher order models for the EORTC QLQ-C30.
        Qual Life Res. 2012 Nov; 21 (Epub 2011 Dec 21. PMID: 22187352; PMCID: PMC3472059): 1607-1617https://doi.org/10.1007/s11136-011-0082-6